Page 1341 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

2 References

31. Atz AM, Wessel DL. Inhaled nitric oxide in sickle cell disease 45. Yeung KY, Lessin LS. Splenic infarction in sickle cell-
with acute chest syndrome. Anesthesiology. 1997;87:988. hemoglobin C disease. Demonstration by selective splenic arte-
32. Sullivan KJ, Goodwin SR, Evangelist J, et al. Nitric oxide suc- riogram and scintillation scan. Arch Intern Med. 1976;136:905.
cessfully used to treat acute chest syndrome of sickle cell disease 46. Emond AM, Holman R, Hayes RJ, et al. Priapism and impo-
in a young adolescent. Crit Care Med. 1999;27:2563. tence in homozygous sickle cell disease. Arch Intern Med.
33. Gladwin MT, Sachdev V, Jison M, et al. Pulmonary hyperten- 1980;140:1434.
sion as a risk factor for death in patients with sickle cell disease. 47. Mantadakis E, Cavender JD, Rogers ZR, et al. Prevalence of
N Engl J Med. 2004;350:886. priapism in children and adolescents with sickle cell anemia. J
34. Gladwin MT. Prevalence, risk factors and mortality of Pediatr Hematol Oncol. 1999;21:518.
pulmonary hypertension defined by right heart catheteriza- 48. Bialecki ES, Bridges KR. Sildenafil relieves priapism in patients
https://kat.cr/user/tahir99/
tion in patients with sickle cell disease. Expert Rev Hematol. with sickle cell disease. Am J Med. 2002;113:252.
2011;4(6):593-596. 49. Marchant WA, Walker I. Anaesthetic management of the child
35. Gladwin MT, Machado RF. Pulmonary hypertension in sickle with sickle cell disease. Paediatr Anaesth. 2003;13:473.
cell disease. N Engl J Med. 2011;365(17):1646-1647. 50. Platt A, Eckman JR, Beasley J, et al. Treating sickle cell pain:
36. Fonseca GH, Souza R, Salemi VM, et al. Pulmonary hyper- an update from the Georgia comprehensive. J Emerg Nurse.
tension diagnosed by right heart catheterization in sickle cell 2002;28:297.
disease. Eur Respir J. 2012;39:112-118. 51. Telen MJ. Principles and problems of transfusion in sickle cell
37. Parent F, Bachir D, Inamo J, et al. A hemodynamic study of disease. Semin Hematol. 2001;38:315.
pulmonary hypertension in sickle cell disease. N Engl J Med. 52. King KE, Ness PM. Treating anemia. Hematol Oncol Clin North
2011;365(1):44-53. Am. 1996;10:1305.
38. Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical 53. Weiner DL, Hibberd PL, Betit P, et al. Preliminary assessment of
sequelae of intravascular hemolysis and extracellular plasma inhaled nitric oxide for acute vaso-occlusive crisis in pediatric
hemoglobin: a novel mechanism of human disease. JAMA. patients with sickle cell disease. JAMA. 2003;289:1136.
2005;293(13):1653-1662. 54. Morris CR, Morris SM Jr., Hagar W, et al. Arginine therapy: a
39. Morris CR, Kato GJ, Poljakovic M, et al. Dysregulated arginine new treatment for pulmonary hypertension in sickle cell dis-
metabolism, hemolysis-associated pulmonary hypertension, ease? Am J Respir Crit Care Med. 2003;168:63.
and mortality in sickle cell disease. JAMA. 2005;294(1):81-90. 55. Stocker JW, De Franceschi L, McNaughton-Smith GA, et al.
40. Kato GJ, McGowan V, Machado RF, et al. Lactate dehydrogenase ICA-17043, a novel Gardos channel blocker, prevents sickled
as a biomarker of hemolysis-associated nitric oxide resistance, red blood cell dehydration in vitro and in vivo in SAD mice.
priapism, leg ulceration, pulmonary hypertension, and death in Blood. 2003;101:2412.
patients with sickle cell disease. Blood. 2006;107(6):2279-2285. 56. Ataga KI, Reid M, Ballas SK, et al. Improvements in haemolysis
41. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebro- and indicators of erythrocyte survival do not correlate with
vascular accidents in sickle cell disease: rates and risk factors. acute vaso-occlusive crises in patients with sickle cell disease: a
Blood. 1998;91:288. phase III randomized, placebo-controlled, double-blind study
42. Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by of the Gardos channel blocker senicapoc (ICA-17043). Br J
transfusions in children with sickle cell anemia and abnormal Haematol. 2011;153(1):92-104.
results on transcranial Doppler ultrasonography. N Engl J Med. 57. Orringer EP, Casella JF, Ataga KI, et al. Purified poloxamer 188
1998;339:5. for treatment of acute vaso-occlusive crisis of sickle cell disease:
43. Prengler M, Pavlakis SG, Prohovnik I, et al. Sickle cell disease: a randomized controlled trial. JAMA. 2001;286:2099.
The neurological complications. Ann Neurol. 2002;51:543. 58. Anthi A, Machado RF, Jison ML, et al. Hemodynamic and
44. Emond AM, Collis R, Darvill D, et al. Acute splenic sequestra- functional assessment of patients with sickle cell disease
tion in homozygous sickle cell disease: Natural history and and pulmonary hypertension. Am J Respir Crit Care Med.
management. J Pediatr. 1985;107:201. 2007;175(12):1272-1279.

Section07-O-ref.indd 2 1/21/2015 11:26:52 AM